J&J to pump another $13B into its MedTech business with Shockwave deal
Johnson & Johnson is pumping more money into heart care with a roughly $13 billion deal for Shockwave Medical, which specializes in technology that helps open clogged arteries.
The health care giant said Friday that it will spend $335 in cash for each share of Shockwave. The total deal value includes cash acquired.
The deal has already been approved by the boards of directors from both companies.
Founded in 2009, Shockwave focuses on intravascular lithotripsy technology that uses sonic pressure waves to crack calcium lesions in arteries and restore blood flow. It’s similar to a technique used to break up kidney stones. The soundwave emitters are placed inside angioplasty catheters to reach the calcified areas of the artery.
Shockwave’s technology is used to treat coronary artery and peripheral artery disease.
The company’s revenue jumped 49% last year to $730 million.
Related articles
- PRAGUE (AP) — Dylan Cozens scored a short-handed goal in overtime for Canada to edge the Czech Repub2024-05-22
China's Puyuan Ramps up Efforts to Develop Knitwear Industry
Contact Us HomeNewsHighlightACWF NewsSocietyWom2024-05-22'Mom's Taste' Brings Wealth to Women
Contact Us HomeNewsHighlightACWF NewsSocietyWom2024-05-22- The Chinese embassy in the United States on Friday strongly rebuked the smearing words on China adop2024-05-22
Politically motivated crimes in Germany reached their highest level in 2023 since tracking began
BERLIN (AP) — Politically motivated crime in Germany last year reached its highest level since the g2024-05-22Wondrous Xinjiang: Project Renovating Old Residences Revitalizes Ancient City
Contact Us HomeNewsHighlightACWF NewsSocietyWom2024-05-22
atest comment